Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1147620
PUBLISHER: Grand View Research | PRODUCT CODE: 1147620
PEGylated Proteins Market Size, Share & Trends Analysis Report By Protein Type (CSF, Interferons), By Application (Cancer, Hepatitis), By Product & Services (Consumables, Services), By End-user, And Segment Forecasts, 2022 - 2030
PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PEGylated Proteins Market Growth & Trends:
The global PEGylated proteins market size is expected to reach USD 3.06 billion by 2030, registering a CAGR of 11.71% over the forecast period, according to a new report by Grand View Research, Inc. PEGylation is the process of attaching polyethylene glycol polymer chains to molecules, such as therapeutics, medication, or vesicle, covalently & non-covalently. The industry is anticipated to grow significantly over the projected period, primarily as a result of the rising demand for PEGylation, an increase in the prevalence of chronic diseases, and the existence of potent new treatment candidates.PEGylated compounds also have certain additional benefits that contribute to the industry expansion, including increased proteolytic protection, a longer half-life, lower toxicity, and lower immunogenicity.
On the other hand, increased PEGylation process costs and the patent expiration of some medications are anticipated to restrain industry expansion to some extent. However, the growing preference for protein-based medications over non-protein-based drugs and the improvement of protein stability and circulation half-life by PEGylation is expected to propel the PEGylated protein industry growth in the forecast period. The rising incidence of chronic diseases like cancer, kidney disease, and rheumatoid arthritis is the main factor contributing to the industry's expansion. For instance, the IARC (International Agency for Research on Cancer) estimates that there were 10.3 million cancer deaths and 19.3 million new cases of cancer worldwide in 2020.
Furthermore, 16.4 million people are expected to die from cancer-related causes by 2040, out of an estimated 29.5 million new instances of the disease per year. In addition, 37.7 million people worldwide were diagnosed HIV positive in 2020, according to the Global HIV and AIDS Statistics 2021 fact sheet from the Joint United Nations Program on HIV/AIDS (UNAIDS). As a result, the demand for producing medicines is anticipated to rise along with the burden of chronic & infectious diseases across the globe. This will encourage research and propel the industry's growth. It is anticipated that COVID-19 had a positive effect on the industry.
According to a study titled "PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives alleviate SARS-CoV-2-mediated hyper-inflammatory responses," published in June 2021, in SARS-CoV-2 ICU patients, PEGylated Nanoparticle Albumin-Bound (PNAB)-steroidal Ginsenoside can successfully reduce plasma levels of histone H4 and NETosis-related factors and reduce SREBP2-mediated systemic inflammation. PNAB-steroidal ginsenoside drugs may help treat coagulation and cytokine storm symptoms that are common in severe SARS-CoV-2 patients. Therefore, the COVID-19 pandemic had a favorable impact on the industry given the considerable research activities conducted using PEGylation technology.
In addition, the industry expansion is being boosted by the rising investments made in R&D projects by pharmaceutical and biotechnology firms. For instance, in March 2022, CRO FairJourneyBiologics S.A., the parent company of Flow Eighteen38, a division of protein sciences, established to enhance and expedite antibody characterization as well as protein purification projects, announced an investment of EUR 5 million (USD 5.58 million) into the division's protein production and physical and biological characterization capabilities and services. Such investments are anticipated to supplement the overall market growth. In addition, there is a discernible trend toward industry consolidation over the past years, with key players forming strategic partnerships to support the R&D projects.
For instance, in February 2022, Merck KGaA acquired Exelead, a biopharmaceutical CDMO with a focus on PEGylated pharmaceuticals and intricate injectable formulations, incorporating Lipid Nanoparticle (LNP)-based drug delivery technology. Furthermore, in July 2022, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), Doxorubicin hydrochloride (Celdoxome pegylated liposomal) was recommended for approval for the cure of advanced ovarian cancer, metastatic breast cancer, AIDS-related Kaposi's sarcoma, and progressing multiple myeloma. Thus, propelling the industry's growth.
PEGylated Proteins Market Report Highlights:
- The consumables product & service segment accounted for the largest share in 2021 due to the growing usage of kit-based PEGylation product lines
- The colony-stimulating factor protein type segment held a larger share in 2021. Colony-stimulating chemicals speed up the development of blood cells and improve their functionality, therefore they help boost a person's immune system while they are receiving cancer treatment
- Thus, extensive use of colony-stimulating factors in oncology will promote the growth of this segment
- The cancer application segment held a larger share in 2021 due to the high incidence of cancer worldwide and the use of peptide therapy for cancer
- The pharmaceutical & biotechnology companies end-user segment held the largest share in 2021
- The rising R&D expenditure by biotechnology and pharmaceutical firms for PEGylated protein will further boost the segment growth
- North America was the largest region in 2021 due to the high use of biological medications for the treatment of chronic diseases, such as monoclonal antibodies, erythropoietin, and interferon, as well as rising government funding, funding for research activities, and ongoing projects for PEGylated protein
- Asia Pacific is expected to grow at the highest CAGRover the forecast period due to the rising prevalence of target diseases and high PEGylated protein adoption
Product Code: GVR-4-68039-990-1
Table of Contents
Chapter 1 Methodology And Scope
- 1.1 Research Methodology
- 1.2 Research Assumptions
- 1.2.1 Estimates And Forecast Timeline
- 1.3 Research Methodology
- 1.4 Information Procurement
- 1.4.1 Purchased Database
- 1.4.2 Gvr's Internal Database
- 1.4.3 Secondary Sources
- 1.4.4 Primary Research
- 1.5 Information Or Data Analysis
- 1.5.1 Data Analysis Models
- 1.6 Market Formulation & Validation
- 1.7 Model Details
- 1.7.1 Commodity Flow Analysis
- 1.7.1.1 Approach 1: Commodity Flow Approach
- 1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
- 1.7.1 Commodity Flow Analysis
- 1.8 Global Market: CAGR Calculation
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1:
- 1.11.2 Objective 2:
Chapter 2 Executive Summary
- 2.1 Market Snapshot, 2021
Chapter 3 Market Variables, Trends & Scope
- 3.1 Market Segmentation & Scope
- 3.2 Market Dynamics
- 3.2.1 Market Drivers Analysis
- 3.2.1.1 Increasing Adoption Of Proteins Based Drugs
- 3.2.1.2 Advantages Of Pegylation Of Therapeutic Proteins
- 3.2.1.3 Increased Spending On R&D Of Biologics
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 High cost of production process for PEGylation
- 3.2.2.2 Patent expiration for novel PEGylated biologics
- 3.2.1 Market Drivers Analysis
- 3.3 Penetration and Growth Prospect Mapping, 2021
- 3.4 COVID - 19 Impact Analysis
- 3.5 PEGylated Proteins Market Analysis Tools
- 3.5.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
- 3.5.2 Porter's Five Forces Analysis
Chapter 4 Product & Services Business Analysis
- 4.1 Pegylated Proteins Market: Product & Services Movement Analysis
- 4.2 Consumables
- 4.2.1 Global Pegylated Proteins Market For Consumables Estimates And Forecast, 2018 - 2030 (USD Million)
- 4.3 Services
- 4.3.1 Global Pegylated Proteins Market For Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Protein Type Business Analysis
- 5.1 PEGylated Proteins Market: Protein Type Movement Analysis
- 5.2 Colony - stimulating factor
- 5.2.1 Global Pegylated Proteins Market For Colony - Stimulating Factor Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.3 Interferons
- 5.3.1 Global Pegylated Proteins Market For Interferons Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.4 Erythropoietin
- 5.4.1 Global Pegylated Proteins Market For Erythropoietin Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.5 Recombinant Factor Vii
- 5.5.1 Global Pegylated Proteins Market For Recombinant Factor Vii Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.6 Others
- 5.6.1 Global Pegylated Proteins Market For Other Proteins Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Application Business Analysis
- 6.1 Pegylated Proteins Market: Application Movement Analysis
- 6.2 Cancer
- 6.2.1 Global Pegylated Proteins Market For Cancer Estimates And Forecast, 2018 - 2030
- 6.3 Autoimmune Diseases
- 6.3.1 Global Pegylated Proteins Market For Autoimmune Diseases Estimates And Forecast, 2018 - 2030
- 6.4 Hepatitis
- 6.4.1 Global Pegylated Proteins Market For Hepatitis Estimates And Forecast, 2018 - 2030
- 6.5 Multiple Sclerosis
- 6.5.1 Global Pegylated Proteins Market For Multiple Sclerosis Estimates And Forecast, 2018 - 2030
- 6.6 Hemophilia
- 6.6.1 Global Pegylated Proteins Market For Hemophilia Estimates And Forecast, 2018 - 2030
- 6.7 Gastrointestinal Disorders
- 6.7.1 Global Pegylated Proteins Market For Gastrointestinal Disorders Estimates And Forecast, 2018 - 2030
- 6.8 Others
- 6.8.1 Global Pegylated Proteins Market For Other Applications Estimates And Forecast, 2018 - 2030
Chapter 7 End - user Business Analysis
- 7.1 PEGylated Proteins Market: End - user Movement Analysis
- 7.2 Pharmaceutical & Biotechnology Companies
- 7.2.1 Global Pegylated Proteins Market For Pharmaceutical & Biotechnology Companies Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.3 Contract Research Organizations
- 7.3.1 Global Pegylated Proteins Market For Contract Research Organizations Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.4 Academic & Research Institutes
- 7.4.1 Global Pegylated Proteins Market For Academic & Research Institutes Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Regional Business Analysis
- 8.1 PEGylated Proteins Market: Regional Movement Analysis
- 8.2 North America
- 8.2.1 North America Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.2.2 U.S.
- 8.2.2.1 U.S. Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.2.3 Canada
- 8.2.3.1 Canada Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Europe Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.2 Germany
- 8.3.2.1 Germany Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.3 France
- 8.3.3.1 France Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.4 U.K.
- 8.3.4.1 U.K. Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.5 Italy
- 8.3.5.1 Italy Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.6 Spain
- 8.3.6.1 Spain Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4 Asia - Pacific
- 8.4.1 Asia - Pacific Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.2 Japan
- 8.4.2.1 Japan Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.3 China
- 8.4.3.1 China Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.4 India
- 8.4.4.1 India Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.5 Australia
- 8.4.5.1 Australia Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.6 South Korea
- 8.4.6.1 South Korea Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Latin America Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.5.2 Brazil
- 8.5.2.1 Brazil Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.5.3 Mexico
- 8.5.3.1 Mexico Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.5.4 Argentina
- 8.5.4.1 Argentina Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6 Middle East And Africa
- 8.6.1 Middle - East And Africa Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.2 South Africa
- 8.6.2.1 South Africa Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.3 Saudi Arabia
- 8.6.3.1 Saudi Arabia PEGylated Proteins market estimates and forecast, 2018 - 2030 (USD Million)
- 8.6.4 UAE
- 8.6.4.1 UAE PEGylated Proteins market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9 COMPETITIVE LANDSCAPE
- 9.1 Strategy Framework
- 9.2 Company Profiles
- 9.2.1 THERMO FISHER SCIENTIFIC, INC.
- 9.2.1.1 Company overview
- 9.2.1.2 Financial performance
- 9.2.1.3 Product benchmarking
- 9.2.1.4 Strategic initiatives
- 9.2.2 ABCAM PLC
- 9.2.2.1 Company overview
- 9.2.2.2 Financial performance
- 9.2.2.3 Product benchmarking
- 9.2.2.4 Strategic initiatives
- 9.2.3 ENZON PHARMACEUTICALS, INC.
- 9.2.3.1 Company overview
- 9.2.3.2 Financial performance
- 9.2.3.3 Product benchmarking
- 9.2.3.4 Strategic initiatives
- 9.2.4 MERCK KGAA
- 9.2.4.1 Company overview
- 9.2.4.2 Financial performance
- 9.2.4.3 Product benchmarking
- 9.2.4.4 Strategic initiatives
- 9.2.5 CELARES GMBH
- 9.2.5.1 Company overview
- 9.2.5.2 Financial performance
- 9.2.5.3 Product benchmarking
- 9.2.5.4 Strategic initiatives
- 9.2.6 PROFACGEN
- 9.2.6.1 Company overview
- 9.2.6.2 Financial performance
- 9.2.6.3 Product benchmarking
- 9.2.6.4 Strategic initiatives
- 9.2.7 CREATIVE PEGWORKS
- 9.2.7.1 Company overview
- 9.2.7.2 Financial performance
- 9.2.7.3 Product benchmarking
- 9.2.7.4 Strategic initiatives
- 9.2.8 NOF CORPORATION
- 9.2.8.1 Company overview
- 9.2.8.1.1 NOF AMERICA CORPORATION
- 9.2.8.2 Financial performance
- 9.2.8.3 Product benchmarking
- 9.2.8.4 Strategic initiatives
- 9.2.9 AURIGENE PHARMACEUTICAL SERVICES LTD.
- 9.2.9.1 Company overview
- 9.2.9.2 Financial performance
- 9.2.9.3 Product benchmarking
- 9.2.9.4 Strategic initiatives
- 9.2.10 LAYSAN BIO, INC.
- 9.2.10.1 Company overview
- 9.2.10.2 Financial performance
- 9.2.10.3 Product benchmarking
- 9.2.10.4 Strategic initiatives
- 9.2.1 THERMO FISHER SCIENTIFIC, INC.
Product Code: GVR-4-68039-990-1
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Global PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 4 Global PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 5 Global PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 6 Global PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 7 Global PEGylated Proteins Market, by Region, 2018 - 2030 (USD Million)
- Table 8 North America PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
- Table 9 North America PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 10 North America PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 11 North America PEGylated Proteins Market, Application, 2018 - 2030 (USD Million)
- Table 12 North America PEGylated Proteins Market, End - user, 2018 - 2030 (USD Million)
- Table 13 U.S. PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 14 U.S. PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 15 U.S. PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 16 U.S. PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 17 Canada PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 18 Canada PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 19 Canada PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 20 Canada PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 21 Europe PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
- Table 22 Europe PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 23 Europe PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 24 Europe PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 25 Europe PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 26 Germany PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 27 Germany PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 28 Germany PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 29 Germany PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 30 U.K. PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 31 U.K. PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 32 U.K. PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 33 U.K. PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 34 France PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 35 France PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 36 France PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 37 France PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 38 Italy PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 39 Italy PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 40 Italy PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 41 Italy PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 42 Spain PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 43 Spain PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 44 Spain PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 45 Spain PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 46 Asia Pacific PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
- Table 47 Asia Pacific PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 48 Asia Pacific PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 49 Asia Pacific PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 50 Asia Pacific PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 51 China PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 52 China PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 53 China PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 54 China PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 55 Japan PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 56 Japan PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 57 Japan PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 58 Japan PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 59 India PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 60 India PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 61 India PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 62 India PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 63 South Korea PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 64 South Korea PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 65 South Korea PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 66 South Korea PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 67 Australia PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 68 Australia PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 69 Australia PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 70 Australia PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 71 Latin America PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
- Table 72 Latin America PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 73 Latin America PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 74 Latin America PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 75 Latin America PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 76 Brazil PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 77 Brazil PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 78 Brazil PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 79 Brazil PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 80 Mexico PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 81 Mexico PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 82 Mexico PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 83 Mexico PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 84 Argentina PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 85 Argentina PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 86 Argentina PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 87 Argentina PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 88 Middle East & Africa PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
- Table 89 Middle East & Africa PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 90 Middle East & Africa PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 91 Middle East & Africa PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 92 Middle East & Africa PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 93 South Africa PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 94 South Africa PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 95 South Africa PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 96 South Africa PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 97 Saudi Arabia PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 98 Saudi Arabia PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 99 Saudi Arabia PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 100 Saudi Arabia PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
- Table 101 UAE PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
- Table 102 UAE PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
- Table 103 UAE PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
- Table 104 UAE PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information Procurement
- Fig. 3 Primary Research Pattern
- Fig. 4 Market Research Approaches
- Fig. 5 Value Chain - Based Sizing & Forecasting
- Fig. 6 Market Formulation & Validation
- Fig. 7 PEGylated Proteins, Market Segmentation
- Fig. 8 Market Snapshot, 2021
- Fig. 9 Market Trends & Outlook
- Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
- Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
- Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- Fig. 13 Porter's Five Forces Analysis
- Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2021
- Fig. 15 Global PEGylated Proteins Market, Product & Services Outlook: Key Takeaways
- Fig. 16 Global PEGylated Proteins Market: Product & Services Movement Analysis
- Fig. 17 Global PEGylated Proteins Market, for Consumables, 2018 - 2030 (USD Million)
- Fig. 18 Global PEGylated Proteins Market, for Services, 2018 - 2030 (USD Million)
- Fig. 19 Global PEGylated Proteins Market, Protein Type Outlook: Key Takeaways
- Fig. 20 Global PEGylated Proteins Market: Protein Type Movement Analysis
- Fig. 21 Global PEGylated Proteins Market, for Colony - stimulating factor, 2018 - 2030 (USD Million)
- Fig. 22 Global PEGylated Proteins Market, for Interferons, 2018 - 2030 (USD Million)
- Fig. 23 Global PEGylated Proteins Market, for Erythropoietin, 2018 - 2030 (USD Million)
- Fig. 24 Global PEGylated Proteins Market, for Recombinant factor VII, 2018 - 2030 (USD Million)
- Fig. 25 Global PEGylated Proteins Market, for Others, 2018 - 2030 (USD Million)
- Fig. 26 Global PEGylated Proteins Market, Application Outlook: Key Takeaways
- Fig. 27 Global PEGylated Proteins Market: Application Movement Analysis
- Fig. 28 Global PEGylated Proteins Market, for Cancer, 2018 - 2030 (USD Million)
- Fig. 29 Global PEGylated Proteins Market, for Autoimmune diseases, 2018 - 2030 (USD Million)
- Fig. 30 Global PEGylated Proteins Market, for Hepatitis, 2018 - 2030 (USD Million)
- Fig. 31 Global PEGylated Proteins Market, for Multiple sclerosis, 2018 - 2030 (USD Million)
- Fig. 32 Global PEGylated Proteins Market, for Hemophilia, 2018 - 2030 (USD Million)
- Fig. 33 Global PEGylated Proteins Market, for Gastrointestinal disorders, 2018 - 2030 (USD Million)
- Fig. 34 Global PEGylated Proteins Market, for Others, 2018 - 2030 (USD Million)
- Fig. 35 Global PEGylated Proteins Market, End - user Outlook: Key Takeaways
- Fig. 36 Global PEGylated Proteins Market: End - user Movement Analysis
- Fig. 37 Global PEGylated Proteins Market, for Pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
- Fig. 38 Global PEGylated Proteins Market, for Contract research organizations, 2018 - 2030 (USD Million)
- Fig. 39 Global PEGylated Proteins Market, for Academic & research institutes, 2018 - 2030 (USD Million)
- Fig. 40 Regional Marketplace: Key Takeaways
- Fig. 41 Global PEGylated Proteins Market: Regional Movement Analysis
- Fig. 42 North America PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 43 U.S. PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 44 Canada PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 45 Europe PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 46 Germany PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 47 U.K. PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 48 France PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 49 Italy PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 50 Spain PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 51 Asia Pacific PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 52 Japan PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 53 China PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 54 India PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 55 Australia PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 56 South Korea PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 57 Latin America PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 58 Brazil PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 59 Mexico PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 60 Argentina PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 61 Middle East and Africa PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 62 South Africa PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 63 Saudi Arabia PEGylated Proteins Market, 2018 - 2030 (USD Million)
- Fig. 64 UAE PEGylated Proteins Market, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.